Concept explainers
Case Summary:
A geneticist student noticed a newborn baby having some physical abnormalities, in a painting during her visit to a museum and wondering whether this condition is a genetic disorder. After searching online, she learned that baby might be having RBS (Roberts syndrome) in which mitotic errors occur. These errors include the premature separation of the centromeres and other heterochromatic regions of homologs in metaphase instead of anaphase. RBS is caused by the ESCO2 gene’s mutant alleles that functions during cell division.
Characters in the case:
A geneticist student, a painting showing a woman (mother) and a newborn baby.
Adequate information:
A newborn baby is having short arms and legs with some facial abnormalities.
To determine:
The reason for premature separation of centromeres causes the problems seen in RBS.
Given the information:
The abnormalities in the newborn baby are reported as Roberts syndrome (RBS) by online searching.
Want to see the full answer?
Check out a sample textbook solutionChapter 11 Solutions
Essentials of Genetics (9th Edition) - Standalone book
- Base on your knowledge of DNA, chromosomes and epigenetics and upon examining the picture below, name two epigenetic factors and at least one non-epigenetic factor present on this picture. [HINT: which of the factors shown on the picture do you expect to change based on the interactions with an environment and which you expect unchanged?] Methyl Group DNA Chromatin Epigenetic Factor Histone Histone Tails Chromosomearrow_forwardA patient who has been diagnosed with cancer has been given a blood test in order for their doctors to investigate their genetic code. What information from the test would help confirm the patient's cancer diagnosis? O Data indicating somatic cell production is being inhibited by the patient's cancer cells Data indicating there is a genetic mutation in a protein controlling the patient's cell's cycle Data indicating gametes are becoming diploid cells due to the introduction of cancerous cells. O Data indicating that cells are increasing their chromosome number due to the occurrence of cancer cells. Next 8:29 AM Previous へロ ) 4/6/2021 12016000076202 F12 Home F10 F11 F8 F9 prisc F6 F7 F5 F3 F4 F1 F2 & #3 $ 7 3 4 * 00arrow_forward1. Assume that figure (A) represents a normal karyotype of this animal. What is the diploid number of thisanimal? 2.Cell (A) contains 3.1 billion (3.1 x 109) base pairs of DNA. Each nucleosome has about 200 bp of DNAwrapped around the histone core.a. What is the maximum number of nucleosomes that can be present in the cell?b. What is the maximum number of H2A histone protein molecules that can be present in the cell?arrow_forward
- You have two patients. Both patients have very low levels of P53 protein. Patient #1 also has very low levels of MDM2 protein; patient #2 has very high levels of MDM2. For each patient briefly describe (briefly justify your answers); Which of the two genes are mutated?P53 or MDM2? Is this an oncogenic or tumor suppressor mutation? Would treatment of the patient with Nutlins be appropriate?arrow_forwardFor the question "4. A previously undiscovered single celled organism was found living at a great depth on the ocean floor. Its nucleus contains only a single, linear chromosome consisting of 7x 106 nucleotide pairs of DNA coalesced with three types of histone-like proteins. The analysis of individual nucleosomes revealed that each unit contained one copy of each protein and that the short linker DNA had no protein bound to it If the entire chromosome consists of nucleosomes (discounting any linker DNA), how many are there and how many total proteins are needed to form them?" I was given the answer below: As per question the chromosome contains 7×106 base pairs of DNA, The number of nucleosomes, each containing 7 × 102 base pairs, is equal to : 7 × 106 /7 × 102 = 104 nucleosomes I was wondering how they knew each nucleosome contains 7 × 102 base pairs?arrow_forwardGenetic instability in the form of point mutations, chromosome rearrangements, and epigenetic changes needs to be maximal to allow the development of cancer. (a) With diagrams explain, chromosome rearrangementarrow_forward
- Solid Wire Models of Cell Division 1- Get four solid wires, 2 long (1 green and 1 red) and two short (1 green and 1 red). This will represent the chromatin in a cell. The wires of the same length are homologous. Red wires will represent the chromatin from the female parent while green wires represent the chromatin from the male parent. Label the chromatin as follows: long green- 1a short green- 2c long red- 1b short red- 2d 2- Let the cell pass S phase. Replicate or duplicate each chromatin fiber. Do this by getting another set of wire identical to the original set. Label as before. 3- Combine the replicated chromatin fiber using masking tape. The tape will also mark the position of the centromere. For the short chromatin, place the tape exactly at the middle while for the long chromatin, place it at a point % from the end of the wire. 4- Assume that the chromosome fibers are folded. This will now represent the chromosomes. OR Varrow_forwardLS1-4 Dolly the Sheep, was born in 1996 in Scotland. She was the first mammal ever cloned from a single cell. The scientist created Dolly in a lab using three mothers: Sheep A provided the egg, Sheep B provided the DNA, and Sheep C carried the embryo to term. During this process, Dolly's cells went through several phases of mitotic growth. Which statement represents the processes of both the somatic cell cycle and cell differentiation? A student scratches his arm causing skin cells to fall off. These cells are soon replaced by identical ones and the student does not notice. A baby is growing in its mother's womb from a tiny ball of cells to an 8lb baby boy. Hematopoietic stem cells (HSCS) turn into different blood cells in a girl's hip bone. O A teenager undergoes a growth spurt one summer.arrow_forwardGenes are not always active in cells. The cell has evolved to edit its chromatin state in accord with the energy needs of the cell and organism. What are these two kinds of chromatin called and how does chromatin modeling work in cells? Name four of the known families of chromatin remodeling complexes enzyme complexes that act directly on DNA to alter nucleosome composition in transcribed regions.arrow_forward
- Who Owns Your Genome? John Moore, an engineer working on the Alaska oil pipeline, was diagnosed in the mid-1970s with a rare and fatal form of cancer known as hairy cell leukemia. This disease causes overproduction of one type of white blood cell known as a T lymphocyte. Moore went to the UCLA Medical Center for treatment and was examined by Dr. David Golde, who recommended that Moores spleen be removed in an attempt to slow down or stop the cancer. For the next 8 years, John Moore returned to UCLA for checkups. Unknown to Moore, Dr. Golde and his research assistant applied for and received a patent on a cell line and products of that cell line derived from Moores spleen. The cell line, named Mo, produced a protein that stimulates the growth of two types of blood cells that are important in identifying and killing cancer cells. Arrangements were made with Genetics Institute, a small start-up company, and then Sandoz Pharmaceuticals, to develop the cell line and produce the growth-stimulating protein. Moore found out about the cell line and its related patents and filed suit to claim ownership of his cells and asked for a share of the profits derived from the sale of the cells or products from the cells. Eventually, the case went through three courts, and in July 1990n years after the case beganthe California Supreme Court ruled that patients such as John Moore do not have property rights over any cells or tissues removed from their bodies that are used later to develop drugs or other commercial products. This case was the first in the nation to establish a legal precedent for the commercial development and use of human tissue. The National Organ Transplant Act of 1984 prevents the sale of human organs. Current laws allow the sale of human tissues and cells but do not define ownership interests of donors. Questions originally raised in the Moore case remain largely unresolved in laws and public policy. These questions are being raised in many other cases as well. Who owns fetal and adult stem-cell lines established from donors, and who has ownership of and a commercial interest in diagnostic tests developed through cell and tissue donations by affected individuals? Who benefits from new genetic technologies based on molecules, cells, or tissues contributed by patients? Are these financial, medical, and ethical benefits being distributed fairly? What can be done to ensure that risks and benefits are distributed in an equitable manner? Gaps between technology, laws, and public policy developed with the advent of recombinant DNA technology in the 1970s, and in the intervening decades, those gaps have not been closed. These controversies are likely to continue as new developments in technology continue to outpace social consensus about their use. Should the physicians at UCLA have told Mr. Moore that his cells and its products were being commercially developed?arrow_forwardWho Owns Your Genome? John Moore, an engineer working on the Alaska oil pipeline, was diagnosed in the mid-1970s with a rare and fatal form of cancer known as hairy cell leukemia. This disease causes overproduction of one type of white blood cell known as a T lymphocyte. Moore went to the UCLA Medical Center for treatment and was examined by Dr. David Golde, who recommended that Moores spleen be removed in an attempt to slow down or stop the cancer. For the next 8 years, John Moore returned to UCLA for checkups. Unknown to Moore, Dr. Golde and his research assistant applied for and received a patent on a cell line and products of that cell line derived from Moores spleen. The cell line, named Mo, produced a protein that stimulates the growth of two types of blood cells that are important in identifying and killing cancer cells. Arrangements were made with Genetics Institute, a small start-up company, and then Sandoz Pharmaceuticals, to develop the cell line and produce the growth-stimulating protein. Moore found out about the cell line and its related patents and filed suit to claim ownership of his cells and asked for a share of the profits derived from the sale of the cells or products from the cells. Eventually, the case went through three courts, and in July 1990n years after the case beganthe California Supreme Court ruled that patients such as John Moore do not have property rights over any cells or tissues removed from their bodies that are used later to develop drugs or other commercial products. This case was the first in the nation to establish a legal precedent for the commercial development and use of human tissue. The National Organ Transplant Act of 1984 prevents the sale of human organs. Current laws allow the sale of human tissues and cells but do not define ownership interests of donors. Questions originally raised in the Moore case remain largely unresolved in laws and public policy. These questions are being raised in many other cases as well. Who owns fetal and adult stem-cell lines established from donors, and who has ownership of and a commercial interest in diagnostic tests developed through cell and tissue donations by affected individuals? Who benefits from new genetic technologies based on molecules, cells, or tissues contributed by patients? Are these financial, medical, and ethical benefits being distributed fairly? What can be done to ensure that risks and benefits are distributed in an equitable manner? Gaps between technology, laws, and public policy developed with the advent of recombinant DNA technology in the 1970s, and in the intervening decades, those gaps have not been closed. These controversies are likely to continue as new developments in technology continue to outpace social consensus about their use. Do you think that donors or patients who provide cells and/or tissues should retain ownership of their body parts or should share in any financial benefits that might derive from their use in research or commercial applications?arrow_forwardDiscuss Concepts A forensic scientist obtained a small DNA sample from a crime scene. In order to examine the sample, he increased its quantity by cycling the sample through the polymerase chain reaction. He estimated that there were 50,000 copies of the DNA in his original sample. Derive a simple formula and calculate the number of copies he will have after15 cycles of the PCR.arrow_forward
- Biology: The Dynamic Science (MindTap Course List)BiologyISBN:9781305389892Author:Peter J. Russell, Paul E. Hertz, Beverly McMillanPublisher:Cengage LearningBiology: The Unity and Diversity of Life (MindTap...BiologyISBN:9781305073951Author:Cecie Starr, Ralph Taggart, Christine Evers, Lisa StarrPublisher:Cengage LearningHuman Heredity: Principles and Issues (MindTap Co...BiologyISBN:9781305251052Author:Michael CummingsPublisher:Cengage Learning